Wilson Mark Andrew bought NKTR
December 13, 2024 · Form 4 insider transaction
Wilson Mark Andrew bought 325,000 shares of Nektar Therapeutics at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
325,000
Price
$0.00
Total value
N/A
InsiderWilson Mark Andrew
RoleOfficer
CompanyNektar Therapeutics (NKTR)
SecurityStock Option
Transaction codeA: Grant or award
Transaction dateDecember 13, 2024
Filing dateDecember 17, 2024
Shares owned after325,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Stock options vest over four years from the date of grant, (December 13, 2024) in equal monthly installments based on continued service.